CancerFax
TREATMENT TECHNOLOGY

WHOLE-BODY HYPERTHERMIA
HOW IT WORKS AND WHO BENEFITS

For metastatic and disseminated disease โ€” where local hyperthermia cannot reach โ€” systemic warming of the entire body to 39โ€“42ยฐC amplifies chemotherapy effect and engages the immune system across every tumour site simultaneously.

analyticsAt a Glance

  • check_circleRaises core body temperature to 39โ€“42ยฐC for 1โ€“6 hours
  • check_circleReaches every tumour site simultaneously โ€” uniquely suited to metastatic disease
  • check_circleUsed alongside systemic chemotherapy for chemosensitisation
  • check_circleActivates innate immunity through heat-shock protein release
Reviewed by: CancerFax Medical Team, Oncology & Haematology SpecialistsLast reviewed: May 29, 20268 min read

What Is Whole-Body Hyperthermia?

Whole-body hyperthermia (WBH) is a systemic thermal therapy that raises the entire body core temperature to 39โ€“42ยฐC, sustained for 1โ€“6 hours depending on the intensity protocol. Unlike regional or local hyperthermia โ€” which heat a defined body region or tumour โ€” WBH heats every tissue simultaneously, making it the only thermal approach that can reach disseminated and metastatic disease.

โ€œFor patients with cancer at multiple sites, no regional applicator can cover them all. WBH is the only thermal therapy designed for systemic disease.โ€
  • Different from Regional Hyperthermia

    Regional hyperthermia focuses heat on a defined body region (pelvis, abdomen, extremity) using external phased-array antennae. WBH raises the entire body โ€” head to feet โ€” making it suitable for metastatic disease that regional systems cannot cover.

  • Different from Whole-Body Sauna or Fever

    WBH is a precisely controlled medical procedure with continuous core temperature monitoring, cardiovascular support, and target temperatures higher than recreational sauna or natural fever. It requires medical supervision throughout.

The Three Intensity Levels of Whole-Body Hyperthermia

WBH is delivered at three distinct intensity levels โ€” each with different temperatures, durations, indications, and physiological demands. The right intensity depends on the patient's condition, the cancer type, and the goal of treatment.

  • Mild Whole-Body Hyperthermia (39โ€“40ยฐC, 4โ€“6 hours)

    Sometimes called fever-range hyperthermia. The body is held at temperatures equivalent to a moderate fever for several hours. Well-tolerated, may be used without sedation. Primary mechanism is immune activation โ€” increasing natural killer cell activity and lymphocyte trafficking. Used in advanced solid tumours, particularly in combination with immunotherapy.

  • Moderate Whole-Body Hyperthermia (40โ€“41ยฐC, 2โ€“4 hours)

    The most common clinical WBH protocol. Combines chemosensitisation (drug uptake enhancement) with immune activation. Sedation is typically used. Delivered alongside systemic chemotherapy โ€” sarcoma, melanoma, NSCLC, ovarian cancer protocols are the most established indications.

  • Extreme/Severe Whole-Body Hyperthermia (41.5โ€“42ยฐC, 1โ€“2 hours)

    Aggressive protocol with strong cytotoxic effect on cancer cells. Requires general anaesthesia, intensive monitoring, and physiological reserve. Pioneered by Robins and colleagues in the 1990s. Used rarely today โ€” physiological demands and modern alternatives have largely shifted practice toward moderate WBH.

  • Choosing the Right Intensity

    Patient performance status, cardiac and pulmonary reserve, and the cancer type all factor in. Frail patients tolerate mild WBH well but rarely receive extreme protocols. Most modern programmes default to moderate WBH (40โ€“41ยฐC) as the optimal balance of efficacy and tolerability.

How Whole-Body Heat Is Delivered

Several technical approaches are used in clinical WBH. The choice depends on the centre, intensity protocol, and patient anatomy.

SystemHeating MethodTypical UseWhere Available
Aquatherm / Heckel HT3000 Infrared CabinetWater-filtered infrared-A radiation penetrates skin; tightly controlled temperature mappingMild and moderate WBH (39โ€“41ยฐC)Germany, Switzerland, selected European centres
Iratherm SeriesInfrared cabinet system with full-body coverageModerate WBH; commonly combined with chemotherapyGermany and several Asian centres
Thermal Blanket SystemsConvective warming via circulating heated air or water blanketsMild WBH; can be done as outpatientVarious centres globally
Extracorporeal Blood HeatingBlood circulated through external heating circuit and returned warmedExtreme WBH (41.5โ€“42ยฐC); requires arterial-venous accessVery limited; specialist German and Russian programmes
Modulated Electrohyperthermia for WBHRadiofrequency capacitive heating; partial-body or regional adapted to systemic protocolAdjunct to systemic chemo in some Asian programmesSelected centres in China and Asia

Who Benefits from Whole-Body Hyperthermia

WBH is most useful in scenarios where disseminated or systemic disease cannot be reached by regional hyperthermia, where standard chemotherapy alone has limited effect, and where the patient has enough physiological reserve to tolerate the procedure.

  • Advanced Sarcoma and Melanoma

    Metastatic soft tissue sarcoma and advanced melanoma have been the most studied indications for moderate WBH combined with cisplatin-based or other chemotherapy. Selected centres report meaningful response rates in heavily pre-treated patients.

  • Advanced Non-Small-Cell Lung Cancer (NSCLC)

    WBH combined with carboplatin and other systemic agents has been used in advanced NSCLC, particularly in heavily pre-treated patients with limited remaining options. Evidence is largely from German and Chinese institutional series.

  • Combined with Immunotherapy

    The immune-activating effects of mild and moderate WBH have led to growing interest in combining it with checkpoint inhibitors. The hypothesis is that heat-induced antigen release and dendritic cell maturation may enhance immunotherapy response, particularly in tumours otherwise considered "cold."

  • Not Suitable for All Patients

    Patients with significant cardiac disease (ejection fraction <50%), severe lung disease, uncontrolled infection, recent stroke, or end-stage organ failure are not WBH candidates. The procedure puts physiological stress on cardiovascular and respiratory systems. Pre-treatment cardiopulmonary evaluation is mandatory.

What to Expect During a WBH Session

A standard moderate WBH session takes 4โ€“6 hours from start to finish. Here is what happens in a specialist programme.

  1. 1

    Step 1: Pre-Treatment Assessment

    Cardiopulmonary evaluation including ECG, echocardiogram, and lung function testing. IV access established and continuous monitoring set up (ECG, oxygen saturation, core temperature via oesophageal or rectal probe).

  2. 2

    Step 2: Sedation and Positioning

    Light to moderate sedation is administered (the patient remains responsive but comfortable). The patient is positioned in the infrared cabinet or under the thermal blanket. Cooling provisions for the head are in place to prevent cerebral overheating.

  3. 3

    Step 3: Heating Phase

    Body temperature is gradually raised over 60โ€“90 minutes using infrared, blanket, or other systems. Target core temperature (typically 40โ€“41ยฐC) is achieved and maintained. Vital signs are continuously monitored; medication adjusts haemodynamics as needed.

  4. 4

    Step 4: Chemotherapy Infusion During Plateau

    Systemic chemotherapy is infused once the plateau temperature is reached and stable. The drug-heat overlap is critical for the chemosensitisation effect. Patient is closely monitored for haemodynamic and metabolic changes.

  5. 5

    Step 5: Cooling and Recovery

    Active cooling is initiated to safely return core temperature to baseline. Sedation is reversed. The patient is monitored in a recovery area for several hours. Most patients are discharged the same day or after overnight observation.

Benefits and Limitations of WBH

WBH offers capabilities no other thermal therapy provides โ€” but with corresponding physiological demands.

Benefits

  • Reaches Disseminated DiseaseThe only thermal therapy that can address tumours at multiple sites simultaneously.
  • Amplifies Chemotherapy Effect SystemicallyProvides chemosensitisation across all tumour deposits in the body, not just one region.
  • Activates Innate ImmunityHeat-shock protein release and immune cell activation may enhance response to immunotherapy.
  • Non-Invasive DeliveryNo surgery, no catheters, no probes inside tumours โ€” delivered through the skin via infrared or blankets.
  • Single-Day Outpatient (Mild WBH)Mild WBH can often be done as a day procedure without inpatient admission.

Limitations

  • Significant Cardiovascular StressHeat increases heart rate, cardiac output, and oxygen consumption. Not suitable for patients with significant cardiac disease.
  • Limited Centre AvailabilityWBH equipment and expertise are concentrated in Germany and Switzerland. Few centres outside Europe deliver moderate or extreme WBH safely.
  • Mostly Institutional EvidenceMost evidence comes from single-centre series rather than large randomised trials. Patient selection plays a major role in reported outcomes.
  • Requires Sedation and MonitoringModerate and extreme protocols require sedation, anaesthesia support, and continuous monitoring โ€” not as straightforward as regional or superficial hyperthermia.
  • Costly Outside Insurance CoverageWBH is rarely covered by health insurance outside of specialist programmes; self-pay arrangements are common.

Frequently Asked Questions

Common questions about whole-body hyperthermia.

About the Treatment

  • Is whole-body hyperthermia safe?

    Modern WBH at experienced specialist centres has acceptable safety profiles when patients are properly selected and monitored. Mild WBH is well-tolerated by most patients. Moderate and extreme WBH carry more physiological risk and require careful cardiopulmonary screening. Major adverse events are rare in experienced programmes but possible โ€” particularly in patients with underlying cardiovascular disease.

  • Is WBH the same as fever or sauna therapy?

    No. Recreational sauna heats the skin and superficial tissues but does not reliably raise core body temperature above 38ยฐC. Natural fever varies in temperature and duration. WBH is a controlled medical procedure that achieves and maintains specific therapeutic core temperatures (39โ€“42ยฐC) for predetermined durations under continuous monitoring.

  • How is the body heated to 41ยฐC without burning the skin?

    Infrared cabinet systems (Aquatherm/Heckel HT3000) use water-filtered infrared-A radiation that penetrates the skin without causing surface burns. The water filter removes wavelengths that would heat only the skin surface. Heat penetrates several millimetres below the surface and warms the underlying tissues, gradually raising core temperature.

  • Can WBH be combined with regional or local hyperthermia?

    Generally not in the same session โ€” both place significant physiological demand. However, patients may receive different types of hyperthermia at different stages of treatment depending on disease pattern. For example, regional hyperthermia might address bulky pelvic disease while WBH targets systemic dissemination.

Eligibility and Access

  • Am I a candidate for WBH?

    Strong candidates have advanced or metastatic solid tumour disease, ECOG performance status 0โ€“2, adequate cardiac function (typically ejection fraction >50%), normal pulmonary function, and no severe comorbid disease. The treating centre will perform detailed cardiopulmonary evaluation before approving treatment. CancerFax can review your medical records to assess broad suitability.

  • Where can I receive whole-body hyperthermia?

    Germany and Switzerland host the most established WBH programmes globally โ€” Klinik St. Georg, Hyperthermia Center Hannover, Klinik Marinus am Stein, and others have decades of experience. Some Chinese cancer centres offer WBH as part of integrated oncology programmes. WBH availability in the US, UK, and most other regions is limited.

  • What does WBH cost?

    Per-session costs vary substantially. Mild WBH at European specialist clinics typically costs โ‚ฌ1,500โ€“โ‚ฌ3,500 per session. Moderate WBH costs โ‚ฌ3,000โ€“โ‚ฌ6,000 per session. A full treatment course of 4โ€“8 sessions therefore ranges from โ‚ฌ10,000โ€“โ‚ฌ50,000 depending on intensity and protocol. Chinese centres typically offer significantly lower per-session pricing.

How CancerFax Helps

CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.

description
Medical Record Review

We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.

verified_user
Eligibility Coordination

We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.

hub
Hospital Communication

We support appointment coordination, document submission, translation, and direct communication with international departments.

flight
Travel & Admission Support

For international patients, we help with practical coordination โ€” travel planning, hospital admission guidance, and local support.

explore
Treatment & Trial Navigation

If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.

support_agent
End-to-end Coordination

From inquiry through to follow-up, our coordinators provide a single point of contact for the family.

CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.

Is Whole-Body Hyperthermia Right for Your Cancer?

Upload your medical records and our oncology team will review your case โ€” disease extent, prior treatments, and overall fitness โ€” to assess whether WBH alongside chemotherapy or immunotherapy could be part of your treatment plan.

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.